已收盤 10-08 16:00:00 美东时间
0.000
0.00%
Public Invited to Monitor Conference Call at 4:30 p.m. Eastern Time OAKS, Pa., ...
07-17 21:00
Findings From Tezspire® (tezepelumab-ekko) Phase 2a COURSE COPD Study Phase 1 Study on AMG104/AZD8630 (Inhaled Anti-TSLP) in Moderate to Severe Asthma New TAVNEOS® (avacopan) Data in Adults ...
05-01 19:00
THOUSAND OAKS, Calif., Feb. 26, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today announced the opening of its manufacturing site in Central Ohio, the newest in its global operations network an...
02-26 22:00
THOUSAND OAKS, Calif., Feb. 19, 2024 /PRNewswire/ -- Amgen (NASDAQ:AMGN) will host a webcasted call at 1:00 p.m. PT on Thursday, February 22, 2024 to discuss Rare Disease, its newly added fo...
02-20 05:00
215-Acre Mixed-Use Destination in Apopka Recognized as One of the Largest, Most Valuable Land Deals of 2023 in Central Florida Dynamic Development to Feature Hotels, Multifamily, Condominium...
01-12 03:47
Apellis Pharmaceuticals Inc (NASDAQ: APLS) announced an update on the ongoing review of its marketing application for intravitreal pegcetacoplan for geographic atrophy (GA) secondary to age-related macular degeneration (AMD) by the Committee for Medicinal Products for Human Use (CHMP) of the
2023-12-14 22:35
James Bradner, M.D., Joins as Executive Vice President, Research and Development, and Chief Scientific Officer David M. Reese, M.D., Named Executive Vice President and Chief Technology Offi...
2023-12-14 22:00
Sponsorship of the Golf Event Continues Following Horizon Acquisition Golfers Shane Lowry, Pádraig Harrington, Séamus Power and Brendan Lawlor Will Become Amgen Golf Ambassadors THOUSAND OAK...
2023-12-14 18:00
Multiple Investigator Sponsored Studies Support the Potential of BLINCYTO® (blinatumomab) Across Acute Lymphoblastic Leukemia Treatment Paradigm New Data Reinforce KYPROLIS® (carfilzomib) as...
2023-12-08 22:00
THOUSAND OAKS, Calif., Dec. 8, 2023 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today a...
2023-12-08 01:00